Clinical trial
SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00028015 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00028015 |
|---|---|
| Title | SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer |
| Official title | A Phase II Study of Second-Line SarCNU (NSC 364432) in Patients With Recurrent/Metastatic Colorectal Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | SarCNU |
| Enrollment | 18 |
| Start date | Oct 30, 2001 |
| Primary completion | Sep 22, 2003 |
| Completion | Sep 22, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 9, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: